The gradual titration schedule is evidence-based and designed to optimize both efficacy and tolerability over the full treatment course
However, everyone's body is different, so it's always wise to listen to yours and consult a professional if you have concerns, especially if you have existing health conditions
Providers often hold a dose longer than four weeks, and that isn't falling behind
Other family members, demonstrating glutathione S-transferase and peroxidase activities, are involved in cellular defense against toxic, carcinogenic, and pharmacologically active electrophilic compounds
Individual results vary based on medical history, lifestyle, and adherence to a provider-guided plan
At first dispensation, 51% and 49% of dulaglutide users in cohort 1 received 0.75 mg and 1.5 mg dosage formulations, respectively, while 1.5 mg was most common in cohort 2 (82%)